3 false false false false false false false false false false true false false false false false false No description of principal activity 2022-07-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 12658291 2022-07-01 2023-06-30 12658291 2023-06-30 12658291 2022-06-30 12658291 2021-07-01 2022-06-30 12658291 2022-06-30 12658291 2021-06-30 12658291 bus:Director1 2022-07-01 2023-06-30 12658291 bus:Director2 2022-07-01 2023-06-30 12658291 core:WithinOneYear 2023-06-30 12658291 core:WithinOneYear 2022-06-30 12658291 bus:Director1 2022-06-30 12658291 bus:Director1 2023-06-30 12658291 bus:Director2 2022-06-30 12658291 bus:Director2 2023-06-30 12658291 bus:Director1 2021-06-30 12658291 bus:Director1 2022-06-30 12658291 bus:Director2 2022-06-30 12658291 bus:Director1 2021-07-01 2022-06-30 12658291 bus:Director2 2021-07-01 2022-06-30 12658291 bus:Micro-entities 2022-07-01 2023-06-30 12658291 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 12658291 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 12658291 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 12658291 bus:FullAccounts 2022-07-01 2023-06-30
COMPANY REGISTRATION NUMBER: 12658291
Healthme Meds Limited
Filleted Unaudited Financial Statements
30 June 2023
Healthme Meds Limited
Statement of Financial Position
30 June 2023
2023
2022
£
£
£
Fixed assets
3,296
4,409
------
------
Current assets
129,727
89,643
Prepayments and accrued income
2,225
4,533
---------
-------
131,952
94,176
Creditors: amounts falling due within one year
126,976
70,231
---------
-------
Net current assets
4,976
23,945
------
-------
Total assets less current liabilities
8,272
28,354
Provisions for liabilities
37
Accruals and deferred income
7,241
4,692
------
-------
994
23,662
------
-------
Capital and reserves
994
23,662
----
-------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 3 (2022: 2 ).
2. Directors' advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2023
Balance brought forward
Advances/ (credits) to the directors
Amounts repaid
Balance outstanding
£
£
£
£
R Jolly
( 9,625)
( 35,601)
79,180
33,954
N Vaitha
9,111
( 25,011)
31,272
15,372
------
-------
---------
-------
( 514)
( 60,612)
110,452
49,326
------
-------
---------
-------
2022
Balance brought forward
Advances/ (credits) to the directors
Amounts repaid
Balance outstanding
£
£
£
£
R Jolly
( 16,714)
( 18,811)
25,900
( 9,625)
N Vaitha
( 6,415)
15,526
9,111
-------
-------
-------
------
( 16,714)
( 25,226)
41,426
( 514)
-------
-------
-------
------
For the year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 5 April 2024 , and are signed on behalf of the board by:
R Jolly
N Vaitha
Director
Director
Company registration number: 12658291
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 5, Winsor and Newton Building, Whitefriars Avenue, Harrow, Middlesex HA3 5RN.